Renewed and Increased Funding
Today, we relaunch the Cancer Research UK Barts Centre, following its recent successful renewal by the charity, with an award of over £10 million, almost a doubling of its previous investment. These funds will support our research facilities and training programmes for both clinical and non-clinical research students, expanding and accelerating our research.
We are part of CRUK’s Network of research Centres across the UK, an investment of over £220 million in these national collaborations between local universities, the NHS and CRUK that aim to get new treatments and diagnostics to cancer patients sooner.
Staff and students at the Cancer Research UK Barts Centre, Charterhouse Square, in Central London
This is the next phase in the Network’s development, a unique chain of research hubs, of which the Barts Centre is proud to be a part. This new funding will continue bringing together world-class research and medical expertise to provide the best possible results for cancer patients nationwide.
Each Centre specialises in unique areas of research expertise, and at Barts our one overriding objective is to ensure that the research conducted here will benefit cancer patients, primarily by:
- Reducing the burden of disease through prevention
- Increasing the chances of survival through early detection and diagnosis;
- Improving patient survival through the discovery and development of more effective, new and novel therapies; and
- Focusing on cancers of unmet need, in particular pancreatic, lung and oesophageal cancer, as well as more prevalent disease areas, including leukaemia, lymphoma, breast, ovarian and prostate and testicular cancers.
The Centres also aim to raise standards of care and forge links with local communities. Collaboration is key to the success of the Centres network - it enables researchers who do not normally work together to exchange ideas and information more easily.
Our Institute Director, Professor Nick Lemoine, said of the news:
This renewed funding for our Cancer Research UK Barts Centre will have such a significant impact on all of us and the patients that we work towards helping, as well as the wider scientific community, through our research.
It is wonderful to have the work performed by our research and support staff, world-class in its excellent quality, recognised through this award, and it is a great honour for us to receive it.
Thank you from all of us to Cancer Research UK and its supporters.
Sir Harpal Kumar, chief executive of Cancer Research UK, said:
“Together, these Centres accelerate the discovery and development of better treatments for cancer patients. They are a unique opportunity for collaboration, both locally across universities and hospitals, and nationally across the network of Centres.
“I’m particularly pleased that our international panel of experts, which renewed these Centres, stated repeatedly their view that there is no other network like this, of this quality, anywhere else in the world.
“This is an exciting time for cancer research. Emerging treatments like immunotherapy are radically changing the field, we are increasingly able to tailor more treatments
to individual patients, and advances in technology mean we can collect and share more research data than ever before.
“Cancer Research UK’s projections are that we will reach more than 500,000 new diagnoses of cancer a year in the UK by 2035. By that time, our goal is that three in four people will survive their cancer. Funding these Centres is one of the charity’s most important strategic priorities and one which will help us reach this ambition.
“This huge investment is only made possible through generous donations from the public and the tireless fundraising of our supporters.”
The other Cancer Research UK Centres are in: Birmingham; Cambridge; Edinburgh; Glasgow; Manchester; Newcastle; Oxford; Southampton and London - Imperial College; Institute of Cancer Research, King’s College and UCL.
Congratulations to all of the Centres, and we thank the staff and students here at Barts whose work has made our Centre a world-class cancer research institute.